All results
6 results for natural history study development type 1 diabetes
-
Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects
This study is a phase 2 study to Evaluate Efficacy, Safety and Tolerability of HM15211 Treatment for 12 Months in Subjects with Biopsy Confirmed NASH ###…
- Ages
- 18 Years - 70 Years
- Sexes
- All
-
ITN095AI DESIGNATE
This is a multicenter, Phase Ib, open-label, siplizumab dose-finding study in individuals aged 8-45 years with a Type 1 diabetes mellitus (T1DM) diagnosis.…
- Ages
- 8 Years - 45 Years
- Sexes
- All
-
TRACK-FA
This is a natural history study prospectively investigating neuroimaging markers of disease progression in children and adults with Friedreich ataxia (FA).…
- Ages
- 5 Years - N/A
- Sexes
- All
-
mFOLFIRINOX vs. FOLFOX With Nivolumab for First-Line Tx of Metastatic HER2- GE Adendocarcinoma
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil,…
- Ages
- 18 Years - N/A
- Sexes
- All
-
PK sensitivity in fluticasone propionate dry powder inhalers
When a drug company first develops a drug, the company has to show the Food and Drug Administration (FDA) that the drug is safe and effective. If FDA concludes…
- Ages
- 18 Years - 50 Years
- Sexes
- All
-
TrustTSC
This is a Phase 3, global, double-blind, randomized, placebo-controlled study of adjunctive GNX treatment in children and adults with TSC-related epilepsy. The…
- Ages
- 1 Year - 65 Years
- Sexes
- All